Can you provide the last earnings date for PIERIS PHARMACEUTICALS INC?
PIERIS PHARMACEUTICALS INC (PIRS) last reported earnings on 11/12/2024.
PIERIS PHARMACEUTICALS INC (PIRS) Earnings History & Surprises
NASDAQ:PIRS • US7207952026
Current stock price
13.6 USD
-2.53 (-15.69%)
At close:
13.26 USD
-0.34 (-2.5%)
After Hours:
PIRS Earnings overview
Past quarterly earnings results for PIERIS PHARMACEUTICALS INC (PIRS), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- N/A
- Period
- Q4 / 2024
- EPS Estimate
- -$0.06
- Revenue Estimate
- 1.09M
Last Reported
Most Recent- Release Date
- Nov 12, 2024
- Period
- Q3 / 2024
- EPS Reported
- EPS Surprise
- %
- Revenue Surprise
- -100.00%
Beat Rate
Last 8 Quarters 13%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2024 | -0.05 | - | -101.59% | 1.09M | -100.00% | -100.00% | ||
| Q2 2024 | -0.03 | - | -100.76% | 2.289M | -100.00% | -100.00% | ||
| Q1 2024 | -0.06 | - | 99.58% | 53K | 2.289M | -97.68% | -97.26% | |
| Q4 2023 | -0.12 | - | 98.61% | 1.299M | 2.289M | -43.25% | -77.78% | |
| Q3 2023 | 3.20 | -8.98 | 135.65% | 130.77% | 19.52M | 7.899M | 147.12% | 263.50% |
| Q2 2023 | 4.00 | -13.06 | 130.64% | 135.71% | 20.055M | 4.099M | 389.27% | 442.32% |
| Q1 2023 | -14.40 | -11.42 | -26.05% | -157.14% | 1.936M | 6.636M | -70.83% | -82.38% |
| Q4 2022 | -8.80 | -18.77 | 53.11% | 16.76% | 5.846M | 6.641M | -11.97% | -30.76% |
| Q3 2022 | -10.40 | -13.06 | 20.34% | 45.83% | 5.37M | 2.301M | 133.38% | 32.36% |
| Q2 2022 | -11.20 | -8.98 | -24.78% | 44.00% | 3.698M | 10.68M | -65.37% | 12.57% |
| Q1 2022 | -5.60 | -9.38 | 40.32% | - | 10.988M | 11.53M | -4.70% | -29.71% |
| Q4 2021 | -10.57 | -24.48 | 56.81% | 49.17% | 8.443M | 2.503M | 237.32% | 349.81% |
| Q3 2021 | -19.20 | -19.86 | 3.30% | 7.69% | 4.057M | 5.423M | -25.19% | 38.04% |
| Q2 2021 | -20.00 | -21.62 | 7.51% | -177.78% | 3.285M | 2.117M | 55.17% | -70.79% |
| Q1 2021 | -5.60 | -13.87 | 59.63% | - | 15.633M | 6.596M | 137.01% | 17.89% |
| Q4 2020 | -20.80 | -19.31 | -7.70% | - | 1.877M | 3.893M | -51.79% | - |
| Q3 2020 | -20.80 | -10.62 | -95.78% | - | 2.939M | 9.99M | -70.58% | - |
| Q2 2020 | -7.20 | -14.00 | 48.58% | - | 11.246M | 7.918M | 42.03% | - |
| Q1 2020 | -5.60 | -13.55 | 58.66% | - | 13.261M | 9.017M | 47.07% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A
Revenue beat statistics
Revenue beat (4)
0
Average Revenue beat (4)
-85.23%
Max Revenue beat (4)
-43.25%
Min Revenue beat (4)
-100.00%
Analysis
PIRS has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, PIRS reported -85.2% below the revenue estimates on average.
Related analysis
PIERIS PHARMACEUTICALS INC / PIRS Earnings FAQ
Did PIERIS PHARMACEUTICALS INC (PIRS) beat earnings estimates last quarter?
PIERIS PHARMACEUTICALS INC (PIRS) missed EPS estimates and missed revenue estimates in the most recent quarter.